Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447
Year: 2016
Type: letter
Abstract: We thank Treiber et al. (1) for sharing their data in relation to a greater prevalence of painful neuropathy and slower walking speeds in their patients taking a statin. They suggest that some of the differences observed in our study (2) could be explained by treatment with statins. We have used our data to assess if statins may contribute to lower-limb weakness or muscle atrophy and neuropathy.
We have compared our study parameters between patients with type 2 diabetes mellitus (T2DM) on a statin ( n = 16) to those who were not on a statin ( n = 4). The interpretation of our data is limited and cautious because of the small number of patients not …
Source: Diabetes Care
DOI: 10.2337/dci16-0020
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2521561335
